Westminster Health Forum

Next steps for diagnostics and pathology - innovation, collaboration and standards

Morning, Thursday, 2nd April 2020

Central London

THIS EVENT IS CPD CERTIFIED


This conference will consider the next steps for diagnostics and pathology in England - looking at supporting innovation, rolling out networks, and developing standards.


The conference will provide a timely opportunity to discuss the use of technology, artificial intelligence, and genomics to improve the diagnosis of disease.


It will also be an opportunity to discuss the Medicines and Medical Devices Bill announced in the Queen’s Speech, which outlines aims to develop advanced therapies and rapid diagnostics in the UK through:

  • Streamlining regulation,
  • Support for research and the life sciences sector, and
  • Making it easier for hospitals to trial new personalised medicines.

We also expect discussion on the next steps for meeting the commitment in the NHS Long Term Plan to implement pathology networks across England by 2021 and diagnostic imaging networks by 2023.


Speakers

The agenda includes keynote addresses from:

  • Mirella Marlow, Programme Director, Centre for Health Technology Evaluation, NICE;
  • Professor Jo Martin, President, Royal College of Pathologists; and
  • Professor Sir Mark Caulfield, Chief Scientist, Genomics England.

Further speakers include: Dr Saoirse Dolly, Guy’s and St Thomas’ NHS Foundation Trust; Professor Carl Heneghan, University of Oxford; Anna Jewell, Pancreatic Cancer UK; Dr Michael Messenger, University of Leeds; The Leeds Centre for Personalised Medicine and NIHR Leeds MedTech and In-Vitro Diagnostic Co-Operative; Professor Dion Morton, University of Birmingham and West Midlands Genomic Medicine Centre; Dr Steven Powell, Rutherford Diagnostics; Dr Caroline Rubin, Royal College of Radiologists and Dr Darren Treanor, Leeds Teaching Hospitals NHS Trust; Northern Pathology Imaging Co-operative and Royal College of Pathologists


The agenda in summary

  • Rolling out imaging and pathology networks:
    • Integration, utilising shared resources and the role of technology; and
    • Consolidating pathology services, and supporting staff recruitment, development, and retention.
  • Improving diagnostic times for cancer and learning from Rapid Diagnostic Centres;
  • Accelerating the diagnostic process - research funding, developing standards, and upgrading infrastructure;
  • Innovation in diagnostics and pathology - utilising data and artificial intelligence, encouraging uptake, and developing personalised treatments; and
  • Evaluating diagnostic technologies and assessing barriers to adoption.

Engagement with policy officials at this conference

This Westminster Health Forum conference has attracted strong interest from policymakers. It will be an opportunity for stakeholders to engage with officials who have reserved places representing: BEIS; Cabinet Office; DHSC; DIT; MHRA; Office for Life Sciences and the Welsh Government.



Keynote Speaker

Professor Jo Martin

President, Royal College of Pathologists; Professor of Pathology, Queen Mary University of London and Director, Academic Health Sciences, Barts Health NHS Trust

Keynote Speakers

Professor Jo Martin

President, Royal College of Pathologists; Professor of Pathology, Queen Mary University of London and Director, Academic Health Sciences, Barts Health NHS Trust

Mirella Marlow

Programme Director, Centre for Health Technology Evaluation, NICE

Professor Sir Mark Caulfield

Chief Scientist, Genomics England

Chair

Peter Dowd

Speakers

Dr Caroline Rubin

Vice President, Clinical Radiology, Royal College of Radiologists

Luella Trickett

Director, Value & Access, Association of British Healthcare Industries

Dr Darren Treanor

Consultant Pathologist, Leeds Teaching Hospitals NHS Trust; Director, Northern Pathology Imaging Co-operative and Digital Pathology Lead, Royal College of Pathologists

Dr Steven Powell

Chief Diagnostic Officer, Rutherford Diagnostics

Dr Saoirse Dolly

Consultant, Rapid Access Diagnostic Clinic, Guy’s and St Thomas’ NHS Foundation Trust

Anna Jewell

Director, Support, Research and Influencing, Pancreatic Cancer UK

Professor Carl Heneghan

Professor, Evidence-Based Medicine and Director, Centre for Evidence-Based Medicine, University of Oxford

Dr Michael Messenger

Head, Personalised Medicine and Health, Leeds Centre for Personalised Medicine and Health, University of Leeds and Deputy Director, NIHR Leeds In Vitro Diagnostic Co-operative